Stay updated with breaking news from Nasdaq aciu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AC Immune SA (NASDAQ:ACIU – Get Free Report) was the recipient of a large drop in short interest during the month of January. As of January 31st, there was short interest totalling 480,600 shares, a drop of 14.1% from the January 15th total of 559,300 shares. Based on an average daily trading volume, of 127,500 […] ....
Shares of AC Immune SA (NASDAQ:ACIU – Get Free Report) traded up 13.8% during trading on Monday . The company traded as high as $4.92 and last traded at $4.87. 277,917 shares were traded during trading, an increase of 51% from the average session volume of 184,616 shares. The stock had previously closed at $4.28. […] ....
AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer s and Parkinson diseases ABATE Phase 1b/2 AD trial of ACI-24.060. ....
AC Immune Announces Pricing of Underwritten Offering of Common Shares Lausanne, Switzerland, December 15, 2023 – AC Immune SA (Nasdaq: ACIU) (the. ....
AC Immune SA (NASDAQ:ACIU – Get Free Report) fell 6.2% during trading on Tuesday . The stock traded as low as $3.50 and last traded at $3.62. 99,878 shares were traded during mid-day trading, a decline of 70% from the average session volume of 336,394 shares. The stock had previously closed at $3.86. Analyst Ratings […] ....